One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
- :
Price : 100$- Special Price : 50$
IL-23R-Specific Chimeric Antigen Receptor Tregs in Crohn’s Disease: Dawn of a Cellular Immunotherapeutic Era? Free
doi : 10.1093/ecco-jcc/jjae159
Volume 19, Issue 4, April 2025
Association of the HLA-DQA1*05 Allelic Gene Variants with Immunogenicity to Anti-TNF therapeutics—Important Differences Between Infliximab and Adalimumab Open Access
doi : 10.1093/ecco-jcc/jjae172
Definitions, diagnosis, and management of postoperative recurrence in Crohn’s disease patients with permanent ileostomy—a systematic review and meta-analysis
doi : 10.1093/ecco-jcc/jjaf041
Environmental risk factors of inflammatory bowel disease: toward a strategy of preventative health Open Access
doi : 10.1093/ecco-jcc/jjaf042
Higher dietary glycemic index, but not glycemic load, is associated with increased risk of ulcerative colitis: a prospective cohort study
doi : 10.1093/ecco-jcc/jjaf036
Corticosteroid-sparing effects of risankizumab efficacy and safety in patients with moderately to severely active ulcerative colitis Open Access
doi : 10.1093/ecco-jcc/jjaf025
Artificial intelligence-assisted approach to assessing bowel wall thickness in pediatric inflammatory bowel disease using intestinal ultrasound images Open Access
doi : 10.1093/ecco-jcc/jjaf037
Intestinal ultrasound as a prognostic tool in new-onset ulcerative colitis—a Copenhagen IBD Cohort Study
doi : 10.1093/ecco-jcc/jjaf033
GLP-1 Analog Use is Associated With Improved Disease Course in Inflammatory Bowel Disease: A Report from the Epi-IIRN
doi : 10.1093/ecco-jcc/jjae160
The Substantial Role of Sleep, Stress, and Physical Activity in Persistent High Levels of Fatigue in Patients With Inflammatory Bowel Disease: A Longitudinal Trajectory Study Open Access
doi : 10.1093/ecco-jcc/jjae163
Risankizumab Is Associated With Normalization of Biomarkers in Patients With Crohn’s Disease: Results From the Phase 3 ADVANCE, MOTIVATE, and FORTIFY Studies Open Access
doi : 10.1093/ecco-jcc/jjae164
Labor Market Participation and Income in Patients With Inflammatory Bowel Disease Onset Before Young Adulthood—The Role of Disease Severity and Mental Health Open Access
doi : 10.1093/ecco-jcc/jjae165
Impact of Histological Remission for Predicting Clinical Relapse in Crohn’s Disease: A Post Hoc Analysis of the Prospective STORI Cohort
doi : 10.1093/ecco-jcc/jjae167
Fatigue in Patients with Inflammatory Bowel Disease in Remission One Year After Diagnosis (the IBSEN III Study) Open Access
doi : 10.1093/ecco-jcc/jjae170
Use of Modified Multiplier of the Simple Endoscopic Score for Crohn’s Disease Endoscopic Improvement Thresholds Enhances Effect Size Differentiation Between Adalimumab Versus Placebo: A Post Hoc Analysis of the EXTEND Trial Open Access
doi : 10.1093/ecco-jcc/jjae171
Multimodal metagenomic analysis reveals microbial InDels as superior biomarkers for pediatric Crohn’s disease
doi : 10.1093/ecco-jcc/jjaf039
Development and validation of a risk prediction tool for the diagnosis of inflammatory bowel disease in patients presenting in primary care with abdominal symptoms Open Access
doi : 10.1093/ecco-jcc/jjaf044
Comparative real-world effectiveness of ustekinumab versus anti-TNF in Crohn’s disease: 12-month maintenance phase results from the prospective, observational RUN-CD study using propensity score adjustment
doi : 10.1093/ecco-jcc/jjaf051
Patient–donor similarity and donor-derived species contribute to the outcome of fecal microbiota transplantation for ulcerative colitis
doi : 10.1093/ecco-jcc/jjaf054
T-cell branched glycosylation as a mediator of colitis-associated colorectal cancer progression: a potential new risk biomarker in inflammatory bowel disease Open Access
doi : 10.1093/ecco-jcc/jjaf043
The Bidirectional Effects of Periodontal Disease and Oral Dysbiosis on Gut Inflammation in Inflammatory Bowel Disease
doi : 10.1093/ecco-jcc/jjae162
Effectiveness of Transitional Care in Inflammatory Bowel Disease; Development, Validation, and Initial Outcomes of a Transition Success Score Open Access
doi : 10.1093/ecco-jcc/jjae166
Effect of tofacitinib exposure in utero and during breastfeeding on the immune status of exposed child
doi : 10.1093/ecco-jcc/jjaf049
